WallStreetZenWallStreetZen

NASDAQ: ZYNE
Zynerba Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

ZYNE past revenue growth

How has ZYNE's revenue growth performed historically?
Company
N/A
Industry
253.9%
Market
21.8%
ZYNE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
ZYNE's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

ZYNE earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$35.8M
Current Profit Margin
0%

ZYNE Return on Equity

Current Company
-58.2%
Current Industry
12.4%
Current Market
-9.5%
ZYNE's Return on Equity (-58.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when ZYNE announces earnings.

ZYNE Return on Assets

Current Company
-50.3%
Current Industry
3.8%
ZYNE is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ZYNE Return on Capital Employed

Current Company
-67.7%
Current Industry
7.9%
ZYNE's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

ZYNE vs Pharmaceutical Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ZYNE$0.00-$35.61M-$35.83M-100.00%N/A
PAVS$95.59M-$56.22M-$58.51M+79.21%N/A
LCI$308.52M-$105.90M-$192.52M-13.58%N/A
MDVL$39.04M-$44.24M-$49.17M+150.47%N/A
SBFM$490.88k-$2.51M-$2.57M+52.33%N/A
View Top Pharmaceutical Stocks

ZYNE earnings dates

Next earnings date
May 15, 2023

Zynerba Pharmaceuticals Earnings & Revenue FAQ

What were ZYNE's earnings last quarter?

On Invalid Date, Zynerba Pharmaceuticals (NASDAQ: ZYNE) reported Q3 2022 earnings per share (EPS) of -$0.20, up 23.08% year over year. Total Zynerba Pharmaceuticals earnings for the quarter were -$8.68 million. In the same quarter last year, Zynerba Pharmaceuticals's earnings per share (EPS) was -$0.26.

If you're new to stock investing, here's how to buy Zynerba Pharmaceuticals stock.

What was ZYNE's earnings growth in the past year?

As of Q1 2023, Zynerba Pharmaceuticals's earnings has grown year over year. Zynerba Pharmaceuticals's earnings in the past year totalled -$35.83 million.

What is ZYNE's earnings date?

Zynerba Pharmaceuticals's earnings date is Invalid Date. Add ZYNE to your watchlist to be reminded of ZYNE's next earnings announcement.

What was ZYNE's revenue last quarter?

On Invalid Date, Zynerba Pharmaceuticals (NASDAQ: ZYNE) reported Q3 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Zynerba Pharmaceuticals's revenue was $0.00.

What was ZYNE's revenue growth in the past year?

As of Q1 2023, Zynerba Pharmaceuticals's revenue has grown null year over year. Zynerba Pharmaceuticals's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.